AtriCure Stock News

AtriCure (NASDAQ:ATRC) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a report released on Saturday, BidAskClub reports. Several other analysts also recentl

The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week,...

AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AtriCure (ATRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AtriCure (NASDAQ:ATRC) is scheduled to announce its earnings results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.37) per share for the qua

AtriCure Inc. (NASDAQ:ATRC) SVP Justin J. Noznesky sold 10,000 shares of the firm’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $40.00, for a total value

Research analysts at Oppenheimer initiated coverage on shares of AtriCure (NASDAQ:ATRC) in a research report issued to clients and investors on Sunday, Benzinga reports. The firm set an “outperform�

Ladenburg Thalmann Financial Services Inc. boosted its position in AtriCure Inc. (NASDAQ:ATRC) by 770.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange

The market rally should become more selective going forward. Risk reward continues to favor buying down days. Here are the top stocks to buy now.

ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2020

Market forces rained on the parade of AtriCure, Inc. (NASDAQ:ATRC) shareholders today, when the analysts downgraded...

Market forces rained on the parade of AtriCure, Inc. (NASDAQ:ATRC) shareholders today, when the analysts downgraded...

AtriCure Inc. (NASDAQ:ATRC) was the target of some unusual options trading activity on Monday. Stock investors purchased 1,500 call options on the company. This represents an increase of approximately